Vellinga A - Search Results

1

Response to diphtheria booster vaccination in healthy adults: vaccine trial.

Vellinga A, Van Damme P, Joossens E, Goossens H. Vellinga A, et al. BMJ. 2000 Jan 22;320(7229):217. doi: 10.1136/bmj.320.7229.217. BMJ. 2000. PMID: 10642229 Free PMC article. Clinical Trial. No abstract available.

2

Epidemiology of hepatitis B and C in Europe.

Van Damme P, Vellinga A. Van Damme P, et al. Among authors: vellinga a. Acta Gastroenterol Belg. 1998 Apr-Jun;61(2):175-82. Acta Gastroenterol Belg. 1998. PMID: 9658602 Review. No abstract available.

3

Modelling long-term persistence of hepatitis B antibodies after vaccination.

Vellinga A, Van Damme P, Bruckers L, Weyler JJ, Molenberghs G, Meheus A. Vellinga A, et al. J Med Virol. 1999 Feb;57(2):100-3. doi: 10.1002/(sici)1096-9071(199902)57:2<100::aid-jmv2>3.0.co;2-m. J Med Virol. 1999. PMID: 9892391

4

Hepatitis B vaccination in mentally retarded: effectiveness after 11 years.

Vellinga A, Van Damme P, Weyler JJ, Vranckx R, Meheus A. Vellinga A, et al. Vaccine. 1999 Feb 12;17(6):602-6. doi: 10.1016/s0264-410x(98)00240-0. Vaccine. 1999. PMID: 10075168

5

Hepatitis B and C in institutions for individuals with intellectual disability.

Vellinga A, Van Damme P, Meheus A. Vellinga A, et al. J Intellect Disabil Res. 1999 Dec;43 ( Pt 6):445-53. doi: 10.1046/j.1365-2788.1999.00222.x. J Intellect Disabil Res. 1999. PMID: 10622359 Review.

6

Repeated-measures models to evaluate a hepatitis B vaccination programme.

Renard D, Bruckers L, Molenberghs G, Vellinga A, Van Damme P. Renard D, et al. Among authors: vellinga a. Stat Med. 2001 Mar 30;20(6):951-63. doi: 10.1002/sim.699. Stat Med. 2001. PMID: 11252015

7

Analysis of factors influencing vaccine uptake: perspectives from Belgium.

Swennen B, Van Damme P, Vellinga A, Coppieters Y, Depoorter AM. Swennen B, et al. Among authors: vellinga a. Vaccine. 2001 Oct 15;20 Suppl 1:S5-7; discussion S1. doi: 10.1016/s0264-410x(01)00307-3. Vaccine. 2001. PMID: 11587800

8

Second diphtheria booster in adults raises immunity to 92%.

Vellinga A, Van Damme P, Joosens E, van Der Wielen M, Goossens H. Vellinga A, et al. BMJ. 2001 Dec 1;323(7324):1308. doi: 10.1136/bmj.323.7324.1308. BMJ. 2001. PMID: 11731400 Free PMC article. No abstract available.

9

Vaccination coverage estimates by EPI cluster sampling survey of children (18-24 months) in Flanders, Belgium.

Vellinga A, Depoorter AM, Van Damme P. Vellinga A, et al. Acta Paediatr. 2002;91(5):599-603. doi: 10.1080/080352502753711759. Acta Paediatr. 2002. PMID: 12113332

10

Adverse Effects of Amoxicillin for Acute Lower Respiratory Tract Infection in Primary Care: Secondary and Subgroup Analysis of a Randomised Clinical Trial.

Tandan M, Vellinga A, Bruyndonckx R, Little P, Verheij T, Butler CC, Goossens H, Coenen S. Tandan M, et al. Among authors: vellinga a. Antibiotics (Basel). 2017 Dec 13;6(4):36. doi: 10.3390/antibiotics6040036. Antibiotics (Basel). 2017. PMID: 29236038 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters